Search

Author/Creator Jackson, Sam

6. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Issue 5 (29th January 2018)

Authors:
Adams, Michael; Bolshoun, David; Bruce, Tami; Chuang, Rita; DeSantis, Donna; Fiel, Thomas; Fitzgibbons, William; Francyk, David; Geisberg, Harry; Giep, Son; Godbole, Narendra; Haas, Terry; Halpern, Stephen; Inzerello, Anthony; Jennings, William; Kaiser, Scott; Kay, Jennifer; Kirby, William; Lendi...
Journal:
Vaccine
Issue:
Volume 36:Issue 5(2018)
Page Start:
668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age. Issue 31 (17th July 2015)

Authors:
Janssen, Julia M.; Jackson, Sam; Heyward, William L.; Janssen, Robert S.
Journal:
Vaccine
Issue:
Volume 33:Issue 31(2015)
Page Start:
3614
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. INVOKE‐2: A phase 2 randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of AL002 in participants with early Alzheimer's disease. (31st December 2021)

Authors:
Paul, Robert; Jackson, Sam; Ward, Michael; Joshi, Aashka; Castro, Abraham; Yeh, Felix L; Liao, Yijie; Morrison, Glenn
Journal:
Alzheimer's & dementia
Issue:
Volume 17(2021)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗